TRERF1
TRERF1 (transcriptional regulating factor 1, also known as TReP-132, HSA277276, RAPA, dJ139D8.5 and BCAR2) is a nuclear zinc-finger protein that binds DNA and activates transcription. It acts together with the co-activators CBP and p300 to drive expression of CYP11A1. Browse Assay Genie's current range of TRERF1 research reagents below, or read on for the biology behind the target.
TRERF1 is a transcriptional regulator that binds DNA and activates transcription of CYP11A1. Its activity is strengthened through interaction with the co-activators CREBBP (CBP) and EP300 (p300), and the combination produces a synergistic transcriptional activation of CYP11A1. This places the TRERF1 protein within the wider class of transcription factors that recruit chromatin-modifying co-activators to target promoters.
The TRERF1 gene encodes a zinc-finger transcriptional regulating protein. HGNC classifies it within the C2H2-type zinc finger group and among Myb/SANT domain containing proteins, two families associated with nucleic acid and chromatin interactions. UniProt records the protein as localised to the nucleus, consistent with its role in gene regulation. According to RefSeq, alternative splicing gives rise to multiple transcript variants that encode different isoforms. A mouse ortholog, Trerf1, is recognised.
The gene has been known under several names. TReP-132 refers to its function as a transcriptional regulating protein, while the previous HGNC name, breast cancer anti-oestrogen resistance 2 (symbol BCAR2), is still found in older literature alongside the aliases HSA277276, RAPA and dJ139D8.5. Researchers studying transcriptional control of CYP11A1, or co-activator-dependent regulation by CBP/p300, will encounter TRERF1 as a defined partner in this mechanism.
TRERF1 binds DNA and activates transcription, making it a subject for studies of zinc-finger factor function in the nucleus.
TRERF1 interacts with CREBBP and EP300, and the interaction produces synergistic activation of its target gene CYP11A1.
TRERF1 regulates the human gene CYP11A1, so it is relevant to work on how this gene's expression is controlled.
Alternative splicing of the TRERF1 gene yields multiple transcript variants encoding different isoforms, which invites investigation of isoform-specific roles.
TRERF1 is a nuclear zinc-finger protein that binds DNA and activates transcription of CYP11A1. It interacts with the co-activators CREBBP and EP300, and together they produce a synergistic transcriptional activation of CYP11A1.
TRERF1 is also called TReP-132, HSA277276, RAPA, dJ139D8.5 and BCAR2. Its earlier HGNC name was breast cancer anti-oestrogen resistance 2. Alternative splicing produces multiple transcript variants that encode different isoforms.
A mouse ortholog, Trerf1, is listed for the human gene. Cross-species work should be planned with care, so check the datasheet of any product for its validated reactivity.
Co-activators, target genes and orthologs linked to TRERF1 transcriptional regulation.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q96PN7; product specifications from Assay Genie datasheets.